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Background
The presence of microvascular obstruction (MO) assessed
by cardiovascular magnetic resonance imaging (MRI) has
been shown to be a prognostic marker for combined clin-
ical endpoints (including unstable angina and repeat tar-
get vessel revascularization) after ST-elevation myocardial
infarction (STEMI) in a limited number of patients.
Whether the presence and especially the extent of MO
gives also prognostic information for "hard" endpoints
and whether MO adds information independent of tradi-
tional prognostic markers and scores has not been inves-
tigated, yet.
Methods
STEMI patients reperfused by primary angioplasty (n =
408) within 12 hours after symptom onset underwent
contrast-enhanced-MRI at a median of 3 days after the
index event (IQR 2-4). MO was measured 15 minutes
after gadolinium injection with late enhancement
sequences. Clinical follow-up was conducted after 19
months (IQR 10-27). The primary endpoint was defined
as composite of death, non-fatal myocardial reinfarction
and congestive heart failure. Secondary outcomes
included the individual components of the composite
endpoint.
Results
The presence of MO demonstrated the strongest unad-
justed associations with MACE and mortality compared to
traditional markers (unadjusted HR 3.67, 95% CI 1.67-
8.5, p = 0.001; and HR 4.63, 95%CI 1.08-19.84, p = 0.04,
respectively). Furthermore, the risk for MACE and mortal-
ity increased with the extent of MO (Tertiles 1-3: 6%,
16.4%, 24.4%, p < 0.001; and 1.5%, 5.2%, 9.6%, p =
0.01). MO presence showed a strong trend towards higher
occurrence of reinfarction (p = 0.06) and congestive heart
failure (p = 0.07).
In a multivariate Cox regression analysis including all
parameters significant in univariate analysis (TIMI risk-
score, Killip-class, ST-resolution, post-PCI TIMI-flow, inf-
arct size, left-ventricular ejection fraction, endsystolic vol-
ume, age and diabetes mellitus), MO was identified as the
strongest independent predictor for the occurrence of the
composite endpoint (HR 2.60, 95%CI 1.15-5.86, p =
0.02). Apart from MO, diabetes (HR 1.93, 95% CI 1.13-
3.29, p = 0.02), Killip class (HR 1.71, 95%CI 1.20-2.44, p
= 0.003), post-PCI TIMI-flow (HR 1.34, 95%CI 1.00-1.79,
p = 0.05), age (HR 1.03, 95%CI 1.01-1.06, p = 0.02) and
ejection fraction (HR 1.03, 95%CI 1.01-1.05, p = 0.008)
were independently associated with the combined clinical
endpoint.
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In the setting of traditional prognostic markers and scores,
the presence and extent of MO is a strong independent
predictor for the occurrence of death, non-fatal myocar-
dial reinfarction and congestive heart failure after STEMI.Page 2 of 2
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